You are in:Home/Publications/Ion-pairing and reversed phase liquid chromatography for the determination of three different quinolones: enrofloxacin, lomefloxacin and ofloxacin

Prof. Alaa El-Sayed Ahmed Ahmed Amin :: Publications:

Title:
Ion-pairing and reversed phase liquid chromatography for the determination of three different quinolones: enrofloxacin, lomefloxacin and ofloxacin
Authors: A.S. Amin, H.A. Dessouki, and Ibrahim A. Agwa b
Year: 2010
Keywords: Not Available
Journal: Not Available
Volume: Not Available
Issue: Not Available
Pages: Not Available
Publisher: Not Available
Local/International: Local
Paper Link: Not Available
Full paper Not Available
Supplementary materials Not Available
Abstract:

Two simple and sensitive high performance liquid chromatographic (HPLC) methods have been developed for the simultaneous determination of three different quinolones: enrofloxacin, lomefloxacin and ofloxacin in their pure and dosage forms, one with reversed phase HPLC and the other with ion-pair HPLC. In reversed phase HPLC, method (A), the mobile phase consists of 2.18% aqueous solution of KH2PO4 with pH adjusted to 2.4±0.2 with acetonitrile (80:20; v/v), the mobile phase pumped at flow rate of 1.2mlmin−1. A Neucleosil C18 column (10μm, 100Å), 250mm length×4.6mm diameter was utilized as stationary phase. Detection was affected spectrophotometrically at 294nm. While in ion-pair HPLC, method (B), the mobile phase was aqueous solution of 0.65% sodium perchlorate and 0.31% ammonium acetate adjusted to pH 2.2±0.2 with orthophosphoric acid: acetonitrile (81:19; v/v), the mobile phase pumped at flow rate of 1.5mlmin−1. A μ bondapack C18 column (10μm, 100Å), 250mm length×4.6mm diameter was utilized as stationary phase. Detection was affected spectrophotometrically at 294nm. Linearity ranges for enrofloxacin, lomefloxacin and ofloxacin were 4.0–108, 7.0–112 and 8.0–113μgml−1, respectively using method A and 8.0–112, 7.0–112 and 5.0–105μgml−1, respectively applying method B. Minimum detection limits obtained were 0.013, 0.023 and 0.035μgml−1 for enrofloxacin, lomefloxacin and ofloxacin, respectively using method A, and 0.028, 0.023 and 0.011μgml−1 using method B. The proposed methods were further applied to the analysis of enrofloxacin in injection and tablets containing the ofloxacin and lomefloxacin drugs, and the results were satisfied.

Google ScholarAcdemia.eduResearch GateLinkedinFacebookTwitterGoogle PlusYoutubeWordpressInstagramMendeleyZoteroEvernoteORCIDScopus